Attached files
file | filename |
---|---|
EXCEL - IDEA: XBRL DOCUMENT - ORAMED PHARMACEUTICALS INC. | Financial_Report.xls |
10-Q - 10-Q - ORAMED PHARMACEUTICALS INC. | zk1211676.htm |
EX-31.1 - EXHIBIT 31.1 - ORAMED PHARMACEUTICALS INC. | exhibit_31-1.htm |
EX-31.2 - EXHIBIT 31.2 - ORAMED PHARMACEUTICALS INC. | exhibit_31-2.htm |
EX-32.2 - EXHIBIT 32.2 - ORAMED PHARMACEUTICALS INC. | exhibit_32-2.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
In connection with the quarterly report of Oramed Pharmaceuticals Inc. (the “Company”) on Form 10-Q for the period ended May 31, 2012 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Nadav Kidron, `President, Chief Executive Officer and Director of the Company, certify, pursuant to 18 U.S.C. section 1350, that to my knowledge:
|
(1)
|
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities and Exchange Act of 1934; and
|
|
(2)
|
The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.
|
Dated: July 12, 2012
|
By:
|
/s/ NADAV KIDRON
|
|||
Name: Nadav Kidron
Title: President, Chief Executive Officer and Director
|